Search / Trial NCT06236087

Overdose Prevention Centers and Behavioral Health

Launched by NYU LANGONE HEALTH · Jan 24, 2024

Trial Information

Current as of October 08, 2024

Not yet recruiting

Keywords

Description

Aims 1 and 2 of this study will use secondary data to identify sources of heterogeneous impacts of OPC use on fatal and nonfatal overdose risk (Aim 1) and estimate the impact of OPC use on treated psychiatric events among clients with histories of PSU (Aim 2). Aim 3 of this study will use qualitative interviews with harm reduction staff to assess barriers and facilitators of integrating mental health services into existing syringe service and OPC delivery models.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aims 1 and 2:
  • * are 18 years of age or older;
  • * engaged in syringe service program and/or overdose prevention center services in New York City in the past 30 days before the date of enrollment;
  • * are able to complete assessments in English or Spanish;
  • * are competent to give written informed consent at the time of the interview;
  • * are able to provide informed consent;
  • * self-report use of illicit opioids (e.g., heroin, fentanyl), illicit stimulants (e.g., powder cocaine, crack, methamphetamine), counterfeit prescription pills (defined as prescription pills obtained through the illicit drug market) or any injection drug use in the past 30 days, and
  • * are able to participate for at least 6 months following enrollment.
  • Aim 3
  • * are 18 years of age or older;
  • * are employed by a harm reduction program;
  • * are able to complete assessments in English; and
  • * are able to provide informed consent.
  • Exclusion Criteria:
  • • Individuals not meeting the criteria detailed above for the respective Aims will not be eligible for participation in this study.

About Nyu Langone Health

NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.

Locations

New York, New York, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0